- Home
- GAME vs PYPD Comparison
GAME vs PYPD Comparison
Compare GAME & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GAME
- PYPD
- Stock Information
- Founded
- GAME 2011
- PYPD 2008
- Country
- GAME United States
- PYPD Israel
- Employees
- GAME N/A
- PYPD N/A
- Industry
- GAME
- PYPD Medical/Dental Instruments
- Sector
- GAME
- PYPD Health Care
- Exchange
- GAME Nasdaq
- PYPD Nasdaq
- Market Cap
- GAME 23.4M
- PYPD 25.0M
- IPO Year
- GAME 2009
- PYPD 2020
- Fundamental
- Price
- GAME $0.75
- PYPD $2.66
- Analyst Decision
- GAME Strong Buy
- PYPD Strong Buy
- Analyst Count
- GAME 3
- PYPD 2
- Target Price
- GAME $3.67
- PYPD $10.50
- AVG Volume (30 Days)
- GAME 283.0K
- PYPD 10.9K
- Earning Date
- GAME 04-15-2025
- PYPD 05-07-2025
- Dividend Yield
- GAME N/A
- PYPD N/A
- EPS Growth
- GAME N/A
- PYPD N/A
- EPS
- GAME N/A
- PYPD N/A
- Revenue
- GAME $96,198,101.00
- PYPD N/A
- Revenue This Year
- GAME $28.71
- PYPD N/A
- Revenue Next Year
- GAME $19.00
- PYPD N/A
- P/E Ratio
- GAME N/A
- PYPD N/A
- Revenue Growth
- GAME 132.91
- PYPD N/A
- 52 Week Low
- GAME $0.50
- PYPD $2.30
- 52 Week High
- GAME $1.67
- PYPD $5.09
- Technical
- Relative Strength Index (RSI)
- GAME 49.75
- PYPD 52.19
- Support Level
- GAME $0.65
- PYPD $2.65
- Resistance Level
- GAME $0.79
- PYPD $2.76
- Average True Range (ATR)
- GAME 0.08
- PYPD 0.10
- MACD
- GAME 0.01
- PYPD 0.03
- Stochastic Oscillator
- GAME 59.04
- PYPD 96.98
About GAME GameSquare Holdings Inc.
GameSquare Holdings Inc is engaged to revolutionize the way brands and game publishers connect with hard-to-reach Gen Z, Gen Alpha, and Millennial audiences. Its next generation media, entertainment, and technology help creators and maximize its brand partners return on investment. Its purpose-built platform, provide marketing and creative services, offer data and analytics solutions, and amplify awareness through FaZe Clan.
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.